Dr. Reinhard Berkels

Co-founder of the start-up Synduct GmbH (www.synduct.com) with the mission to help physicians optimizing patient care. Key achievement: • Chief medical advisor developing the AI-empowered clinical decision support tool Dr.Info (https://www.drinfo.ai/) for healthcare professionals. Launching May 2025.

Co-Leading the development of IQVIA’s enterprise wide Medical Affairs strategy, providing Medical Affairs expertise and building a compelling integrated offering that truly meets the needs of Medical Affairs customers. • Key contributor and subject matter expert for the global Medical Affairs Strategy • Building credibility for IQVIA as a Medical Affairs provider by publishing white papers on Medical Affairs • Forging connections and consulting of senior Medical Affairs professionals in the industry

Leading the German Medical Affairs Immunology teams (59 FTEs) in the therapeutic areas of Rheumatology, Gastroenterology and Dermatology. Driving science, launches, medical education, real world evidence and medical strategy to create patient and company value in a cross functional setting. • Building up of a portfolio ready German medical Immunology organisation. • Successful launches and delivering of RWE plans, driving digital transformation

Build global MSL excellence, strategy and frameworks. Build and implement Medical Affairs governance and processes ensuring global adoption. Implement strategy to establish global medical information excellence. Key contributions included: • Defined and rolled out MSL vision, role and frameworks. • Delivered insights gathering framework with results for medical and brand planning. • Defined and delivered global Medical Affairs policy governing responsibilities and accountabilities.

Headed the entire Europe UCB Medical Affairs Neurology team (70 FTE) provided coaching and mentoring to improve skills and knowledge. Driving science, medical education, real world evidence and medical strategy to create patient and company value in a cross functional setting. Key achievements included: • Stand-alone Medical Affairs launch of a paediatric indication for an Epilepsy drug. • Key contribute in designing a new go to market model for European Neurology unit.

Build up a new team to link UCB Immunology Medical Affairs across the globe concerning MSLs, medical information, training and real-world evidence. Created synergies by sharing knowledge across the globe building a global community. Some key achievements included: - Established global synergy creation for medical information standard responses. - Built-up of a globally interacting Medical Affairs Immunology community sharing best practice. - Setting up of a Real World Evidence network in Europe.

Benchmarked UCB Immunology MSL performance and setting up of metrics. Devised and implemented medical strategy and training initiatives through active collaboration with Medical, Commercial, Market Access, Operational Excellence and other European and global functions working in a matric structure. Key achievements included: • Established and implemented MSL metrics documenting MSL activity value. • Ensured implementation of Medical Affairs strategy in Europe creating synergies.

Head of the German UCB Immunology Medical Affairs department (9 FTE) responsible for all Medical Affairs activities in a cross functional setting. Localized and implemented Medical Affairs strategy for Immunology in Germany. Prepared and maintained budget and supported during the launch of a new indication. • Created and executed the medical and scientific strategy for both current and future indications

Medical lead RLS and Parkinsons disease heading the German CNS MSL team (6 MSLs). Built and sustained professional relationships with health care professionals. Administered Medical Affairs CNS budget and allocated resources accordingly. Key achievements included: • Designed, executed, reviewed and published non-interventional studies. • Achieved SmPC wording change relevant for Market Access by cross functional collaboration. • Launching of a new treatment for Restless legs syndrome.

Medical lead for the therapeutic areas of Restles Legs Syndrome and Narcolepsy in Germany responsible for medical and educational activities. Delivered KOL management, support of market access, strategic support of the marketing team and sales force training. Key achievements included: • Provided high level internal and external scientific support in the field of Restless Legs Syndrome and Narcolepsy establishing UCB as a trusted partner to health care professionals.

Medical Manager for the therapeutic area of Epilepsy in Germany responsible for medical activities, medical information and educational activities. Delivered KOL management, strategic support of the marketing team and sales force training. Key contributions: - Part of a cross functional team to prepare and launch a new epilepsy drug in Germany. - Provided high level internal and external scientific support in the field of Epilepsy establishing UCB as a trusted partner to health care professionals.

Established Key Opinion Leader management in the therapeutic areas of Neurology and Diabetic Neuropathic Pain as part of a cross functional team advancing local patient value oriented initiatives (i.e. medical education, scientific meetings, congresses, speaker trainings, IIS requests, round tables, RWE, clinical development, medical information)

Senior Pharmacologist and early Preclinical Project Leader in the area of Diabetic Neuropathic Pain and Parkinsons Disease

Group Leader and Senior Lecturer, Dept. of Anaesthesia, University Hospital of Düsseldorf, Germany (Focus on Myocardial Infarction and the Innate Immune System)

Group Leader and Senior Lecturer, Dept. of Pharmacology, University Hospital of Cologne, Germany (Focus on Cardiovascular Research and Molecular Biology of Transport Proteins)

Group leader, senior lecturer and researcher in the field of cardiovascular pharmacology and genetics of transport proteins

Cardiovascular Research